These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 9787151

  • 1. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH, de Jong D, Maartense E, Schuuring E, Kluin PM.
    Blood; 1998 Nov 01; 92(9):3152-62. PubMed ID: 9787151
    [Abstract] [Full Text] [Related]

  • 2. Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
    Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B, Audisio E, Freilone R, Novero D, Cappia S, De Giuli P, Mazza U, Resegotti L, Palestro G, Saglio G, Gaidano G.
    Genes Chromosomes Cancer; 1996 May 01; 16(1):21-30. PubMed ID: 9162193
    [Abstract] [Full Text] [Related]

  • 3. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.
    Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Yamabe H, Edamura S, Dor S, Mori T, Okuma M, Fukuhara S.
    Br J Haematol; 1996 Jun 01; 93(4):911-20. PubMed ID: 8703825
    [Abstract] [Full Text] [Related]

  • 4. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso J, Medeiros LJ, Yang DT, Nabhan C.
    Cancer; 2016 Feb 15; 122(4):559-64. PubMed ID: 26565895
    [Abstract] [Full Text] [Related]

  • 5. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
    Kawasaki C, Ohshim K, Suzumiya J, Kanda M, Tsuchiya T, Tamura K, Kikuchi M.
    Leuk Lymphoma; 2001 Feb 15; 42(5):1099-106. PubMed ID: 11697627
    [Abstract] [Full Text] [Related]

  • 6. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019 Feb 15; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 7. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas.
    Willenbacher E, Willenbacher W, Weger R, Dominik W, Manzl C, Brunner A.
    Ann Hematol; 2020 Sep 15; 99(9):2125-2132. PubMed ID: 32613279
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N, Uner A, Benekli M, Barista I.
    Cancer; 2012 Sep 01; 118(17):4173-83. PubMed ID: 22213394
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z, Niu J, Cao Y, Pang X, Cui W, Zhang W, Li X.
    J Clin Pathol; 2020 Mar 01; 73(3):126-138. PubMed ID: 31615842
    [Abstract] [Full Text] [Related]

  • 10. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.
    Am J Surg Pathol; 2013 Mar 01; 37(3):323-32. PubMed ID: 23348205
    [Abstract] [Full Text] [Related]

  • 11. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG, Martin V, Bernasconi B, Del Curto B, Pecciarini L, Uccella S, Pruneri G, Ponzoni M, Mazzucchelli L, Martinelli G, Ferreri AJ, Pinotti G, Assanelli A, Scandurra M, Doglioni C, Zucca E, Capella C, Bertoni F.
    Hum Pathol; 2009 May 01; 40(5):645-52. PubMed ID: 19144384
    [Abstract] [Full Text] [Related]

  • 12. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE, Kravchenko SK, Kovrigina AM, Magomedova AU, Plastinina LV, Obukhova TN, Misyurin AV, Misyurin VA, Grebenuk LA, Babaeva FE, Baryakh EA, Vorobiev AI.
    Ter Arkh; 2019 Jul 15; 91(7):52-62. PubMed ID: 32598736
    [Abstract] [Full Text] [Related]

  • 13. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
    Ueda C, Nishikori M, Kitawaki T, Uchiyama T, Ohno H.
    Int J Hematol; 2004 Jan 15; 79(1):52-4. PubMed ID: 14979479
    [Abstract] [Full Text] [Related]

  • 14. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
    Pescarmona E, De Sanctis V, Pistilli A, Pacchiarotti A, Martelli M, Guglielmi C, Mandelli F, Baroni CD, Le Coco F.
    J Pathol; 1997 Nov 15; 183(3):281-6. PubMed ID: 9422982
    [Abstract] [Full Text] [Related]

  • 15. Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.
    McPhail ED, Maurer MJ, Macon WR, Feldman AL, Kurtin PJ, Ketterling RP, Vaidya R, Cerhan JR, Ansell SM, Porrata LF, Nowakowski GS, Witzig TE, Habermann TM.
    Haematologica; 2018 Nov 15; 103(11):1899-1907. PubMed ID: 29903764
    [Abstract] [Full Text] [Related]

  • 16. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.
    Am J Surg Pathol; 2010 Mar 15; 34(3):327-40. PubMed ID: 20118770
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
    Miyaoka M, Kikuti YY, Carreras J, Ikoma H, Hiraiwa S, Ichiki A, Kojima M, Ando K, Yokose T, Sakai R, Hoshikawa M, Tomita N, Miura I, Takata K, Yoshino T, Takizawa J, Bea S, Campo E, Nakamura N.
    Mod Pathol; 2018 Feb 15; 31(2):313-326. PubMed ID: 28984304
    [Abstract] [Full Text] [Related]

  • 18. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.
    Barrans SL, O'Connor SJ, Evans PA, Davies FE, Owen RG, Haynes AP, Morgan GJ, Jack AS.
    Br J Haematol; 2002 May 15; 117(2):322-32. PubMed ID: 11972514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.